Variant report

Variant	nsv960211
Chromosome Location	chr17:67138815-67144978
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:67138624-67138899	HepG2	liver:	n/a	n/a
2	CEBPB	chr17:67142965-67143208	K562	blood:	n/a	n/a
3	CEBPB	chr17:67138645-67138833	HepG2	liver:	n/a	chr17:67138765-67138778 chr17:67138766-67138777
4	CEBPB	chr17:67140043-67140371	K562	blood:	n/a	chr17:67140212-67140223
5	CEBPB	chr17:67138572-67138930	HepG2	liver:	n/a	chr17:67138765-67138778 chr17:67138766-67138777
6	CEBPB	chr17:67138587-67138830	HepG2	liver:	n/a	chr17:67138765-67138778 chr17:67138766-67138777
7	CEBPB	chr17:67143027-67143079	IMR90	lung:	n/a	n/a
8	CEBPB	chr17:67140102-67140265	HepG2	liver:	n/a	chr17:67140212-67140223
9	CEBPB	chr17:67138621-67138873	IMR90	lung:	n/a	chr17:67138765-67138778 chr17:67138766-67138777
10	CEBPD	chr17:67138661-67138866	HepG2	liver:	n/a	n/a
11	E2F4	chr17:67138660-67138868	MCF10A-Er-Src	breast:	n/a	n/a
12	EP300	chr17:67138637-67138866	HepG2	liver:	n/a	chr17:67138745-67138754 chr17:67138744-67138758
13	EP300	chr17:67138635-67138917	SK-N-SH_RA	brain:	n/a	chr17:67138745-67138754 chr17:67138744-67138758
14	FOS	chr17:67138613-67138873	MCF10A-Er-Src	breast:	n/a	n/a
15	FOS	chr17:67138690-67138888	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr17:67138673-67138903	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr17:67138580-67138853	MCF10A-Er-Src	breast:	n/a	n/a
18	FOXA2	chr17:67138631-67138893	HepG2	liver:	n/a	n/a
19	FOXP2	chr17:67138588-67138854	SK-N-MC	brain:	n/a	n/a
20	HNF4A	chr17:67138660-67138899	HepG2	liver:	n/a	chr17:67138750-67138765 chr17:67138750-67138765 chr17:67138749-67138764 chr17:67138751-67138763 chr17:67138750-67138765
21	HNF4A	chr17:67138523-67138879	HepG2	liver:	n/a	chr17:67138750-67138765 chr17:67138750-67138765 chr17:67138749-67138764 chr17:67138751-67138763 chr17:67138750-67138765
22	HNF4G	chr17:67138646-67138857	HepG2	liver:	n/a	chr17:67138750-67138765 chr17:67138750-67138765 chr17:67138748-67138763 chr17:67138751-67138763 chr17:67138750-67138765
23	JUN	chr17:67139336-67139536	K562	blood:	n/a	n/a
24	MYC	chr17:67138580-67138886	MCF10A-Er-Src	breast:	n/a	n/a
25	MYC	chr17:67138583-67138939	MCF10A-Er-Src	breast:	n/a	n/a
26	MYC	chr17:67141823-67141871	MCF-7	breast:	n/a	n/a
27	NFE2	chr17:67139972-67139979	GM12878	blood:	n/a	n/a
28	POLR2A	chr17:67142567-67142718	MCF10A-Er-Src	breast:	n/a	n/a
29	POLR2A	chr17:67139676-67139818	MCF10A-Er-Src	breast:	n/a	n/a
30	POLR2A	chr17:67137535-67138914	MCF10A-Er-Src	breast:	n/a	n/a
31	POLR2A	chr17:67137691-67138959	HUVEC	blood vessel:	n/a	n/a
32	POLR2A	chr17:67138488-67138898	SK-N-MC	brain:	n/a	n/a
33	POLR2A	chr17:67142088-67142288	MCF10A-Er-Src	breast:	n/a	n/a
34	POLR2A	chr17:67137623-67138921	MCF10A-Er-Src	breast:	n/a	n/a
35	POLR2A	chr17:67143572-67143658	Gliobla	brain:	n/a	n/a
36	POLR2A	chr17:67143661-67143776	Gliobla	brain:	n/a	n/a
37	RFX5	chr17:67142719-67142954	K562	blood:	n/a	n/a
38	STAT3	chr17:67137801-67138896	MCF10A-Er-Src	breast:	n/a	chr17:67138265-67138273
39	STAT3	chr17:67140909-67140954	MCF10A-Er-Src	breast:	n/a	n/a
40	STAT3	chr17:67139366-67139582	MCF10A-Er-Src	breast:	n/a	chr17:67139405-67139416
41	STAT3	chr17:67138681-67139092	MCF10A-Er-Src	breast:	n/a	n/a
42	STAT3	chr17:67140136-67140202	MCF10A-Er-Src	breast:	n/a	n/a
43	STAT3	chr17:67144848-67145048	MCF10A-Er-Src	breast:	n/a	n/a
44	STAT3	chr17:67138613-67138879	MCF10A-Er-Src	breast:	n/a	n/a
45	STAT3	chr17:67138688-67138857	MCF10A-Er-Src	breast:	n/a	n/a
46	TBL1XR1	chr17:67141183-67141260	K562	blood:	n/a	n/a
47	TCF12	chr17:67138472-67139129	SK-N-SH	brain:	n/a	n/a
48	TCF12	chr17:67138468-67139001	SK-N-SH	brain:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:67140722..67142523-chr17:67142695..67144218,2	MCF-7	breast:
2	chr17:67138378..67141973-chr17:67143185..67146328,3	K562	blood:
3	chr17:67115279..67117551-chr17:67138552..67141546,2	K562	blood:
4	chr17:67140722..67142523-chr17:67142695..67144218,2	MCF-7	breast:

Variant related genes	Relation type
ABCA6	TF binding region
ENSG00000154263	chromatin interactions

Extended variants
information (count: 302 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:302 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548003174	chr17:67138835-67138836	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs373992962	chr17:67138869-67138870	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs553110586	chr17:67138872-67138873	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs12453914	chr17:67138878-67138879	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs536972394	chr17:67138907-67138908	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs548563178	chr17:67138924-67138925	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs567019480	chr17:67138932-67138933	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs570073916	chr17:67138944-67138945	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs34390202	chr17:67138971-67138972	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs537393820	chr17:67138973-67138974	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs199557678	chr17:67138975-67138976	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs202090562	chr17:67138993-67138994	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs373956850	chr17:67138995-67138996	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs60718457	chr17:67138996-67138997	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs377041136	chr17:67138997-67138998	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs567769261	chr17:67138999-67139000	Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs200907929	chr17:67139011-67139012	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs182139312	chr17:67139018-67139019	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs571001876	chr17:67139102-67139103	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs566702483	chr17:67139104-67139105	Enhancers Flanking Active TSS Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs185985113	chr17:67139168-67139169	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs80229706	chr17:67139203-67139204	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs572119635	chr17:67139219-67139220	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs74895423	chr17:67139226-67139227	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs373914654	chr17:67139242-67139243	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs149496601	chr17:67139312-67139313	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs577982407	chr17:67139318-67139319	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs575927108	chr17:67139346-67139347	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs543052635	chr17:67139366-67139367	Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs143946544	chr17:67139429-67139430	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs532103712	chr17:67139457-67139458	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs117030332	chr17:67139473-67139474	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs73356149	chr17:67139474-67139475	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs192107208	chr17:67139557-67139558	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs184091209	chr17:67139563-67139564	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs570410595	chr17:67139566-67139567	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs138670613	chr17:67139568-67139569	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs552641681	chr17:67139569-67139570	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs570840880	chr17:67139657-67139658	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs188635192	chr17:67139668-67139669	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs553158402	chr17:67139676-67139677	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs565877848	chr17:67139709-67139710	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs536013659	chr17:67139762-67139763	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs376368419	chr17:67139809-67139810	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs572178289	chr17:67139820-67139821	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs142672980	chr17:67139853-67139854	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs575964105	chr17:67139861-67139862	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs372611567	chr17:67139873-67139874	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs558152274	chr17:67139877-67139878	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs542418240	chr17:67139885-67139886	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Neuroblastoma	18923191	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21509527	CNVD
Chordoma	18071362	CNVD
Cancer	16751803	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	21523713	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	21364760	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Breast cancer	21858162	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
Cancer	21129771	CNVD
Congenital generalized hypertrichosis terminalis	19463983	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Gingival hyperplasia	19463983	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Neuroblastoma	20406844	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16417655	CNVD
Breast cancer	21045282	CNVD
Epilepsy	22083797	CNVD
Sezary syndrome	18413736	CNVD
Honadal dysgenesis	21408189	CNVD
Basal cell lymphoma	17053054	CNVD
Acute monocytic leukemia	16498392	CNVD

Chromatin state (count:124 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:67096200-67143400	Weak transcription	Psoas Muscle	Psoas
2	chr17:67101200-67143400	Weak transcription	Pancreas	Pancrea
3	chr17:67114600-67162800	Weak transcription	Brain Angular Gyrus	brain
4	chr17:67124800-67150000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
5	chr17:67127000-67143400	Weak transcription	Fetal Intestine Large	intestine
6	chr17:67127000-67150600	Weak transcription	Sigmoid Colon	Sigmoid Colon
7	chr17:67130600-67146200	Weak transcription	Lung	lung
8	chr17:67132000-67151600	Weak transcription	Rectal Mucosa Donor 31	rectum
9	chr17:67133800-67145600	Weak transcription	Fetal Muscle Trunk	muscle
10	chr17:67134400-67143400	Weak transcription	Left Ventricle	heart
11	chr17:67134600-67145000	Weak transcription	Skeletal Muscle Male	skeletal muscle
12	chr17:67136200-67139000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr17:67137600-67139000	Enhancers	HepG2	liver
14	chr17:67137600-67139200	Enhancers	Breast Myoepithelial Primary Cells	Breast
15	chr17:67137800-67141200	Enhancers	Monocytes-CD14+_RO01746	blood
16	chr17:67137800-67141400	Enhancers	Primary monocytes fromperipheralblood	blood
17	chr17:67138000-67139600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
18	chr17:67138000-67154000	Weak transcription	Rectal Smooth Muscle	rectum
19	chr17:67138200-67139200	Weak transcription	Fetal Stomach	stomach
20	chr17:67138200-67143400	Weak transcription	Skeletal Muscle Female	skeletal muscle
21	chr17:67138200-67150600	Weak transcription	Brain Cingulate Gyrus	brain
22	chr17:67138200-67151200	Weak transcription	Rectal Mucosa Donor 29	rectum
23	chr17:67138200-67151600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
24	chr17:67138200-67152200	Weak transcription	Fetal Muscle Leg	muscle
25	chr17:67138400-67139800	Weak transcription	Colon Smooth Muscle	Colon
26	chr17:67138600-67139600	Enhancers	Muscle Satellite Cultured Cells	--
27	chr17:67138600-67140000	Enhancers	HUVEC	blood vessel
28	chr17:67138600-67142000	Enhancers	Osteobl	bone
29	chr17:67138600-67147800	Weak transcription	Duodenum Smooth Muscle	Duodenum
30	chr17:67138600-67155400	Weak transcription	Brain Anterior Caudate	brain
31	chr17:67138800-67139400	Enhancers	Liver	Liver
32	chr17:67138800-67139400	Weak transcription	Fetal Lung	lung
33	chr17:67138800-67139600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr17:67138800-67139800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr17:67138800-67139800	Enhancers	Adipose Nuclei	Adipose
36	chr17:67138800-67140000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr17:67138800-67140000	Weak transcription	Small Intestine	intestine
38	chr17:67138800-67141200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr17:67138800-67141200	Weak transcription	Ovary	ovary
40	chr17:67138800-67141800	Weak transcription	Right Atrium	heart
41	chr17:67138800-67142000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
42	chr17:67138800-67142000	Enhancers	NHDF-Ad	bronchial
43	chr17:67138800-67152000	Weak transcription	Stomach Smooth Muscle	stomach
44	chr17:67138800-67162800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr17:67138800-67182000	Weak transcription	Brain Inferior Temporal Lobe	brain
46	chr17:67139000-67139200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr17:67139000-67139400	Weak transcription	HepG2	liver
48	chr17:67139200-67141800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr17:67139200-67143400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
50	chr17:67139400-67139600	Enhancers	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links